312 related articles for article (PubMed ID: 37867519)
1. The role of the thyroid in polycystic ovary syndrome.
Fan H; Ren Q; Sheng Z; Deng G; Li L
Front Endocrinol (Lausanne); 2023; 14():1242050. PubMed ID: 37867519
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature.
Palomba S; Colombo C; Busnelli A; Caserta D; Vitale G
Front Endocrinol (Lausanne); 2023; 14():1251866. PubMed ID: 37635968
[TBL] [Abstract][Full Text] [Related]
3. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.
Benetti-Pinto CL; Berini Piccolo VR; Garmes HM; Teatin Juliato CR
Fertil Steril; 2013 Feb; 99(2):588-92. PubMed ID: 23103018
[TBL] [Abstract][Full Text] [Related]
4. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
Elife; 2023 Aug; 12():. PubMed ID: 37534878
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Polycystic Ovary Syndrome (PCOS) on the Risk of Developing Ovarian Cancer and Thyroid Disorders: A Comprehensive Review.
Mukherjee P; Sanyal S; Chadha S; Mukherjee S
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):562-572. PubMed ID: 37986267
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study.
Bedaiwy MA; Abdel-Rahman MY; Tan J; AbdelHafez FF; Abdelkareem AO; Henry D; Lisonkova S; Hurd WW; Liu JH
J Womens Health (Larchmt); 2018 May; 27(5):659-664. PubMed ID: 29620956
[TBL] [Abstract][Full Text] [Related]
7. Is There a Relation between Hypothyroidism and Polycystic Ovary Syndrome and its Metabolic Components?
Bonakdaran S; Milani N; Khorasani ZM; Hosseinzadeh M; Kabiri M
Curr Diabetes Rev; 2023; 19(2):e260422204034. PubMed ID: 35980060
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.
Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ
Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388
[TBL] [Abstract][Full Text] [Related]
9. Subclinical hypothyroidism is not a risk factor for polycystic ovary syndrome in obese women of reproductive age.
Zhang B; Wang J; Shen S; Liu J; Sun J; Gu T; Zhu D; Bi Y
Gynecol Endocrinol; 2018 Oct; 34(10):875-879. PubMed ID: 29658805
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS.
van der Ham K; Stekelenburg KJ; Louwers YV; van Dorp W; Schreurs MWJ; van der Wal R; Steegers-Theunissen RPM; Laven JSE
Front Endocrinol (Lausanne); 2023; 14():1245106. PubMed ID: 37854182
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
12. [Hypothyroidism in the developing stage of the woman with comorbid polycystic ovary.].
Cignarelli A
Recenti Prog Med; 2023 Dec; 114(12):6e-10e. PubMed ID: 38031865
[TBL] [Abstract][Full Text] [Related]
13. Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS.
Trakakis E; Pergialiotis V; Hatziagelaki E; Panagopoulos P; Salloum I; Papantoniou N
Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28672734
[TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
15. [Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome].
Yue F; Zhang D; Gong F; Zhang L; Sun Z; Lei M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):940-946. PubMed ID: 28872086
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome - an update.
Boyle J; Teede HJ
Aust Fam Physician; 2012 Oct; 41(10):752-6. PubMed ID: 23210095
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome and chronic autoimmune thyroiditis.
Novais Jde S; Benetti-Pinto CL; Garmes HM; Jales RM; Juliato CR
Gynecol Endocrinol; 2015 Jan; 31(1):48-51. PubMed ID: 25211537
[TBL] [Abstract][Full Text] [Related]
18. Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review.
Peddemul A; Tejovath S; Hassan D; K Patel K; Sikandar R; Kahlon SS; Nair S; Mostafa JA
Cureus; 2022 Aug; 14(8):e28468. PubMed ID: 36176844
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
Lowenstein EJ
Dermatol Ther; 2006; 19(4):210-23. PubMed ID: 17004997
[TBL] [Abstract][Full Text] [Related]
20. Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome - A Cross-sectional Study from Bangladesh.
Kamrul-Hasan A; Aalpona FTZ; Selim S
Eur Endocrinol; 2020 Oct; 16(2):156-160. PubMed ID: 33117449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
